Replay LSI2021 Emerging Medtech Summit

Play Now

The COVID Impact on Global Medical Devices & Diagnostics Markets: 2020 Review & 2021 Forecast

158 Pages | 28 Exhibits | Forecasts Through 2021
market-report-samples/GlobalMarketSegments2.jpg market-report-samples/GlobalMarketSegments3caps.jpg market-report-samples/GlobalMarketSegmentsCaps.jpg
Buy Now
Talk to Sales

Overview

The year 2020 has been both devastating and energizing for the global MD&D industry as a whole. The COVID-19 pandemic, whose impact first shut down and then curtailed routine medical, hospital and surgical care around the world, delayed normal market growth which, even now, is threatened by a possible second, mutation-induced pandemic. Hardest hit have been companies that serve surgical markets and those dominated by office- and clinic-based services, e.g., aesthetics, hearing, dental. On the other hand, developers of IVD tests that diagnose the SARS-CoV-2 virus and manufacturers of infection control disposables, critical care and respiratory products have seen their revenues skyrocket to the point that some have been unable to keep up with demand. The result has been a roller coaster but mostly disappointing year for the industry, although MD&D companies can take comfort in the knowledge that they have not faced these hardships by themselves and, as an industry, have actually responded to the pandemic with great competence, ingenuity and care for their employees, patients, clinicians and stockholders.

Earlier in the year, we published reports providing insights into: 1) the anticipated impact of the COVID-19 pandemic on the global MD&D market by major technology; and 2) MD&D companies’ apparent exposure to the pandemic based on the composition of their product portfolios. The current report provides a wrap up of the year’s positives and negatives. It forecasts 2020 revenues for 50 of the largest MD&D companies by franchise as well as forecasts for nearly 100 technologies grouped into 23 segments for 2020 and 2021. We did not venture beyond 2021 except to comment in the text on how far full recovery for a technology market might stretch into that year.

This new report quantifies the impact that COVID-19 has had on the global MD&D market and forecasts how we expect the market to rebound, by segment and by competitor.

Companies Covered

3M

Abbott Laboratories

AbbVie/Allergan plc

Alcon

Align Technology

Arthrex

Asahi Kasei

B. Braun Melsungen

Baxter International

Becton Dickinson

bioMerieux

Boston Scientific

Canon Medical Systems

Cardinal Health

Coloplast

ConvaTec

Cooper Companies

Danaher Corporation

Demant

Dentsply Sirona

Edwards Lifesciences

Elekta

Envista

Fresenius SE & Co. KGaA

FujiFilm

GE Healthcare

Getinge

Hillrom

Hologic

Intuitive Surgical

Johnson & Johnson

Medtronic

Mölnlycke

Nipro

Olympus Corporation

Philips Healthcare

ResMed

Roche Diagnostics

Siemens Healthineers

Smith & Nephew

Sonova

Steris

Straumann

Stryker

Sysmex

Teleflex

Terumo

Thermo Fisher Scientific

Varian Medical Systems

Zimmer-Biomet

Table of Contents

EXECUTIVE SUMMARY

Impact of COVID-19 Pandemic on MD&D Market by Technology, 2019-2021

Impact of COVID-19 Pandemic on MD&D Companies, 2019-2020

1.0 INTRODUCTION 

2.0 COVID-19 IMPACT ON MD&D MARKETS BY TECHNOLOGY 

2.1 In Vitro Diagnostics (IVD) 

2.2 Diagnostic Imaging 

2.3 Cardiovascular Technologies 

2.3.1 Cardiac Rhythm Management (CRM) 

2.3.2 Transcatheter Technologies 

2.3.3 Cardiac Surgery 

2.4 Orthopedic Technologies

2.4.1 Reconstruction 

2.4.2 Trauma Products 

2.4.3 Spine Products 

2.4.4 Other Products 

2.4.5 Major Orthopedic Trends 

2.5 Dental Technologies 

2.6 Endoscopy 

2.7 Renal & Urology Technologies 

2.8 Drug Delivery 

2.9 Energy-Based Technologies 

2.9.1 Radiation Therapy 

2.9.2 Lasers 

2.9.3 Low Frequency Electromagnetic 

2.9.4 Radiofrequency 

2.9.5 Ultrasound 

2.9.6 Cryo 

2.9.7 Other Energy 

2.10 Wound Care 

2.10.1 Wound Closure 

2.10.2 Advanced Wound Management 

2.11 Critical Care

2.12 Infection Control 

2.13 Hearing Technologies 

2.15 Contact Lenses 

2.16 Ophthalmic Surgery 

2.17 Patient Beds, Wheelchairs, Transport and Aids 

2.18 Aesthetic Technologies 

2.19 Blood Donation & Management 

2.20 Home Respiratory Technologies 

2.21 Surgical Robotics 

2.22 Neurostimulation 

2.23 Surgical Tables, Lights & Fixed 

2.24 Hernia Mesh

3.0 COVID-19 IMPACT ON GLOBAL MD&D COMPANIES 

3.1 Overall Response of Global MD&D Industry to COVID-19 Pandemic 

3.1.1 Company Challenges 

3.1.2 Company Opportunities 

3.2 MD&D Company Revenue Trends and Opportunities

3.2.1 Medtronic 

3.2.1.1 Revenue Impact by Franchise 

3.2.1.2 Outlook 

3.2.2 Johnson & Johnson 

3.2.2.1 Revenue Impact by Franchise 

3.2.2.2 Outlook 

3.2.3 Abbott Laboratories 

3.2.3.1 Revenue Impact by Franchise 

3.2.3.1 Outlook 

3.2.4 Siemens Healthineers 

3.2.4.1 Revenue Impact by Franchise 

3.2.4.2 Outlook 

3.2.5 GE Healthcare 

3.2.5.1 Revenue Impact by Franchise 

3.2.5.2 Outlook 

3.2.6 Stryker 

3.2.6.1 Revenue Impact by Franchise

3.2.6.2 Outlook 

3.2.7 Philips Healthcare 

3.2.7.1 Revenue Impact by Franchise 

3.2.7.2 Outlook 

3.2.8 Becton Dickinson 

3.2.8.1 Revenue Impact by Franchise 

3.2.8.2 Outlook 

3.2.9 Roche Diagnostics 

3.2.9.1 Revenue Impact by Franchise 

3.2.9.2 Outlook 

3.2.10 Boston Scientific  

3.2.10.1 Revenue Impact by Franchise 

3.2.10.2 Outlook 

3.2.11 Zimmer-Biomet 

3.2.11.1 Revenue Impact by Franchise 

3.2.11.2 Outlook 

3.2.12 Baxter International 

3.2.12.1 Revenue Impact by Franchise 

3.2.12.2 Outlook 

3.2.13 Danaher Corporation 

3.2.13.1 Revenue Impact by Franchise 

3.2.13.2 Outlook 

3.2.14 Alcon 

3.2.14.1 Revenue Impact by Franchise 

3.2.14.2 Outlook 

3.2.15 Olympus Corporation 

3.2.15.1 Revenue Impact by Franchise 

3.2.15.2 Outlook 

3.2.16 B. Braun Melsungen 

3.2.16.1 Revenue Impact by Franchise 

3.2.16.2 Outlook 

3.2.17 Fresenius SE & Co. KGaA 

3.2.17.1 Revenue Impact by Franchise 

3.2.17.2 Outlook 

3.2.18 Cardinal Health 

3.2.18.1 Revenue Impact by Franchise 

3.2.18.2 Outlook 

3.2.19 Terumo  

3.2.19.1 Revenue Impact by Franchise 

3.2.19.2 Outlook 

3.2.20 Smith & Nephew 

3.2.20.1 Revenue Impact by Franchise 

3.2.20.2 Outlook 

3.2.21 Thermo Fisher Scientific 

3.2.21.1 Revenue Impact by Franchise 

3.2.21.2 Outlook 

3.2.22 Intuitive Surgical 

3.2.22.1 Revenue Impact by Franchise 

3.2.22.2 Outlook 

3.2.23 Edwards Lifesciences 

3.2.23.1 Revenue Impact by Franchise 

3.2.23.2 Outlook 

3.2.24 AbbVie/Allergan plc 

3.2.24.1 Revenue Impact by Franchise 

3.2.24.2 Outlook 

3.2.25 Dentsply Sirona  

3.2.25.1 Revenue Impact by Franchise 

3.2.25.2 Outlook 

3.2.26 3M 

3.2.26.1 Revenue Impact by Franchise 

3.2.26.2 Outlook 

3.2.27 Canon Medical Systems 

3.2.27.1 Revenue Impact by Franchise 

3.2.27.2 Outlook 

3.2.28 Varian Medical Systems  

3.2.28.1 Revenue Impact by Franchise 

3.2.28.2 Outlook 

3.2.29 Hologic 

3.2.29.1 Revenue Impact by Franchise 

3.2.29.2 Outlook 

3.2.30 FujiFilm 

3.2.30.1 Revenue Impact by Franchise 

3.2.30.2 Outlook 

3.2.31 Sonova  

3.2.31.1 Revenue Impact by Franchise 

3.2.31.2 Outlook 

3.2.32 Envista 

3.2.32.1 Revenue Impact by Franchise 

3.2.32.2 Outlook 

3.2.33 Hillrom  

3.2.33.1 Revenue Impact by Franchise 

3.2.33.2 Outlook 

3.2.34 Cooper Companies 

3.2.34.1 Revenue Impact by Franchise 

3.2.34.2 Outlook 

3.2.35. Coloplast 

3.2.35.1 Revenue Impact by Franchise 

3.2.35.2 Outlook 

3.2.36 Arthrex 

3.2.36.1 Revenue Impact by Franchise 

3.2.36.2 Outlook

3.2.37 Sysmex 

3.2.37.1 Revenue Impact by Franchise 

3.2.37.2 Outlook 

3.2.38 Getinge  

3.2.38.1 Revenue Impact by Franchise 

3.2.38.2 Outlook 

3.2.39 bioMerieux  

3.2.39.1 Revenue Impact by Franchise 

3.2.39.2 Outlook 

3.2.40 ResMed  

3.2.40.1 Revenue Impact by Franchise 

3.2.40.2 Outlook 

3.2.41 Nipro 

3.2.41.1 Revenue Impact by Franchise 

3.2.41.2 Outlook 

3.2.42 Align Technology 

3.2.42.1 Revenue Impact by Franchise 

3.2.42.2 Outlook 

3.2.43 Teleflex 

3.2.43.1 Revenue Impact by Franchise 

3.2.43.2 Outlook 

3.2.44 Demant  

3.2.44.1 Revenue Impact by Franchise 

3.2.44.2 Outlook 

3.2.45 Asahi Kasei 

3.2.45.1 Revenue Impact by Franchise 

3.2.45.2 Outlook 

3.2.46 ConvaTec 

3.2.46.1 Revenue Impact by Franchise 

3.2.46.2 Outlook 

3.2.47 Mölnlycke  

3.2.47.1 Revenue Impact by Franchise 

3.2.47.2 Outlook 

3.2.48 Straumann 

3.2.48.1 Revenue Impact by Franchise 

3.2.48.2 Outlook 

3.2.49 Elekta 

3.2.49.1 Revenue Impact by Franchise 

3.2.49.2 Outlook 

3.2.50 Steris  

3.2.50.1 Revenue Impact by Franchise 

3.2.50.2 Outlook 

 

List of Exhibits

Summary Exhibit 1: Impact of COVID-19 Pandemic on Global Markets for Major MD&D Technologies, 2019-2021

Summary Exhibit 2: Impact of COVID-19 Pandemic on Revenues of 50 Major MD&D Companies, 2019-2020 

Exhibit 2-1: Global Market for In Vitro Diagnostics by Major Category, 2019-2021 

Exhibit 2-2: Global Market for Diagnostic Imaging Equipment, Service & Consumables by Major Category, 2019-2021 

Exhibit 2-3: Global Market for Cardiovascular Technologies by Major Category, 2019-2021 

Exhibit 2-4: Global Market for Cardiovascular Transcatheter Technologies by Major Category, 2019-2021 

Exhibit 2-5: Global Market for Cardiovascular Surgery Technologies by Major Category, 2019-2021 

Exhibit 2-6: Global Market for Orthopedic Technologies by Major Category, 2019-2021 

Exhibit 2-7: Global Market for Dental Technologies by Major Category, 2019-2021 

Exhibit 2-8: Global Market for Endoscopic Technologies by Major Category, 2019-2021 

Exhibit 2-9: Global Market for Renal & Urology Technologies by Major Category, 2019-2021 

Exhibit 2-10: Global Market for Drug Delivery Technologies by Major Category, 2019-2021 

Exhibit 2-11: Global Market for Energy-Based Technologies by Major Category, 2019-2021 

Exhibit 2-12: Global Market for Wound Care Technologies by Major Category, 2019-2021 

Exhibit 2-13: Global Market for Critical Care Technologies by Major Category, 2019-2021 

Exhibit 2-14: Global Market for Infection Control Technologies by Major Category, 2019-2021 

Exhibit 2-15: Global Market for Hearing Technologies by Major Category, 2019-2021 

Exhibit 2-16: Global Contact Lenses Market, 2019-2021 

Exhibit 2-17: Global Market for Ophthalmic Surgery Technologies by Major Category, 2019-2021 

Exhibit 2-18: Global Market for Patient Beds, Wheelchairs, Transport & Aids Technologies by Major Category, 2019-2021 

Exhibit 2-19: Global Market for Aesthetics Technologies by Major Category, 2019-2021 .

Exhibit 2-20: Global Market for Blood Collection & Management Technologies by Major Category, 2019-2021 

Exhibit 2-21: Global Market for Home Respiratory Technologies by Major Category, 2019-2021

Exhibit 2-22: Global Market for Surgical Robotics Technologies by Major Category, 2019-2021 

Exhibit 2-23: Global Market for Neurostimulation Technologies by Major Category, 2019-2021 

Exhibit 2-24: Global Market for Surgical Tables, Lights, Fixed Systems and Service by Major Category, 2019-2021 

Exhibit 2-25: Global Market for Hernia Mesh Technologies, 2019-2021 

Exhibit 3-1: Change in Revenues of Major MD&D Companies from 2019 to 2020 Due to COVID-19 Pandemic 

Our Clients